BrainFectIN
BrainFectIN™ enables nucleic acids delivery into central nervous system of small animals.
Major difficulties with gene delivery in the central nervous system is the weakness of standard non-viral gene carriers and the limitations associated to the use of viral particles (time-consuming and requires additional saftey precautions). Unlike these methods, BrainFectIN™ is an original non-viral formulation that allows safe, easy and efficient nucleic acids delivery into central nervous system of small animals.
This transfection reagent allows transfection of neural cells in specific brain following stereotaxic injection, with low immunogenicity and rapid and long-term transgene expression.
BrainFectIN™ has been designed by our R&D team to meet in vivo grade quality (reagents performed under high manufacturing and quality standards and tested by strict quality controls).
BrainFectIN™ main advantages:
- Targeted process (stereotaxic injection)
- Good transfection efficiency
- Reduction of the injection volume
- Reduction of the DNA doses
- Minimized toxicity
- Low immunogenicity
- Rapid and long-term transgene expression
Sizes:
- 100 µL of BrainFectIN™ / 20-30 injections
- 250 µL of BrainFectIN™ / 40-60 injections
- 500 µL of BrainFectIN™ / 80-120 injections
Storage: -20°C.
Shipping condition: room temperature.
Please log in or register to see the prices for your country
Catalog number | Unit Size | Price excl tax | Quantity / Buy |
IV-BF30100 |
100 µL
|
$165.00
|
|
IV-BF30250 |
250 µL
|
$339.00
|
|
IV-BF30500 |
500 µL
|
$525.00
|
|
Citation database
NAME | MOLECULE VECTOR | PRODUCT | REFERENCE | |
in vivo : brain | miRNA | BrainFectIN | Rapps K. Int J Mol Sci. 2024 Jun 29;25(13):7188. | |
in vivo: Brain | DNA | BrainFectIN | Caccialupi L life sciences 2022 doi: 10.20944/preprints202208.0480.v1 | |
in vivo: Brain | DNA | BrainFectIN | Canella AE. 2022 Thesis dissertation | |
in vivo: Brain | DNA | BrainFectIN | wang C. Biochem Biophys Res Commun. 2011; EPUB. | |
in vivo: Brain | siRNA | BrainFectIN | Mets DG. bioRxiv. doi: https://doi.org/10.1101/2021.05.01.442260 | |
in vivo: Brain | DNA | BrainFectIN | Di Scala C. J Neurosci Methods. 2019 Jan 1;311:295-306. |
Related products